Major Growth Driver Identified in 2025 Antiparasitic Drugs Market: Rising Incidence Of Vector-Borne Diseases Sparks Growth In The Antiparasitic Drugs Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Antiparasitic Drugs Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the market size of antiparasitic drugs has witnessed substantial growth. The market, which is projected to rise from $24.06 billion in 2024 to $25.75 billion in 2025, expects a compound annual growth rate (CAGR) of 7.0%. Factors such as the incidence of parasitic infections, resistance to current therapies, and international health programs are contributors to the growth experienced in the historical period.

Antiparasitic Drugs Market Size Forecast: What's the Projected Valuation by 2029?
The market size of antiparasitic drugs is anticipated to experience robust expansion in the years to come, with a prediction to surge to $33.64 billion in 2029, reflecting a compound annual growth rate (CAGR) of 6.9%. Factors contributing to this growth during the forecast period can include the emergence of new parasitic threats, changes in climate, and diseases transmitted by vectors, along with a heightened focus on global health security and healare accessibility. Key trends predicted during this period encompass advancements in drug developments, specialized treatment approaches, combination therapies, collaborations between public and private sectors, and the use of telemedicine and remote diagnostics.

View the full report here:
https://www.thebusinessresearchcompany.com/report/antiparasitic-drugs-global-market-report

What Are the Drivers Transforming the Antiparasitic Drugs Market?
The upward trend in vector-borne diseases is likely to stimulate the expansion of the antiparasitic drugs market. Vector-borne diseases are essentially infectious ailments that are transferred to humans or other creatures via arthropods, typically insects such as mosquitoes, ticks, and flies. These diseases encompass maladies such as malaria, dengue, and yellow fever. Antiparasitic medications are key in obstructing the proliferation of vector-borne diseases by identifying and eradicating the harmful parasites. Several antiparasitic drugs, namely chloroquine, doxycycline and atovaquone-proguanil, are frequently employed to treat malaria. For instance, the Centers for Disease Control and Prevention, a US government agency, revealed in June 2024 that from January to June 2024 the Americas reported over 9.7 million dengue cases, which is more than twice the 4.6 million cases reported in 2023. Puerto Rico reported 1,498 dengue cases in the United States, with 745 cases being observed among U.S. travelers returning from affected regions. Hence, the escalating number of vector-borne diseases fosters the enlargement of the antiparasitic drugs market. The antiparasitic drugs market is expected to flourish due to the widespread occurrence of parasitic infections. These infections, caused by microscopic parasites or larger organisms, exploit their host organisms, often causing damage or disease. Antiparasitic drugs play a critical role in managing and controlling parasitic infections, contributing to better health outcomes and reducing the collective impact of these diseases on affected individuals and communities. For instance, according to Gov. UK, a British government website, in 2022, a total of 31 cases of rickettsial infection were reported in EWNI, with 30 in England and 1 in Wales. Out of these cases, 17 (55%) were confirmed, while 14 (45%) were categorized as probable cases. Thus, the widespread nature of parasitic infections contributes to the development of the antiparasitic drug market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12927&type=smp

What Long-Term Trends Will Define the Future of the Antiparasitic Drugs Market?
Firms at the forefront of the antiparasitic drugs market are honing their focus on creating novel products like chewable veterinary medications to simplify administration and increase the likelihood of pets adhering to the treatment. These chewable veterinary products, which could be flavorsome tablets or treats, are engineered to deliver drugs to animals and increase their willingness to accept treatment by making it more appealing and less stressful. For instance, in April 2024, a pharmaceutical firm based in Germany that goes by the name 'C.H. Boehringer Sohn AG and Co. KG' brought NexGard Spectra to the market for an all-inclusive control of parasites. NexGard Spectra is a palatable, squashy chew formulated to combat both internal and external parasites in dogs, with its efficacy extending to fleas, ticks, heartworms, and a variety of intestinal worms, all in a single dosage every month. It swiftly neutralizes fleas within four hours of being administered, and proving to be over 99% efficient against various parasites in a matter of hours.

Which Segments in the Antiparasitic Drugs Market Offer the Most Profit Potential?
The antiparasitic drugs market covered in this report is segmented -

1) By Product Type: Anthelmintics, Antiprotozoals, Ectoparasiticide, Other Products
2) By Treatment: Avermectins, Bezimidazoles, Pyrimidines, Organophosphates, Imidazolesthiazoles
3) By Route of Administration: Oral, Injectable, Topical
4) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

Subsegments:
1) By Anthelmintics: Benzimidazoles, Ivermectin, Pyrantel Pamoate, Praziquantel
2) By Antiprotozoals: Metronidazole, Tinidazole, Nitazoxanide, Pentamidine
3) By Ectoparasiticides: Permethrin, Malathion, Lindane, Fipronil
4) By Other Products: Combination Antiparasitic Drugs, Novel Antiparasitic Agents

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12927&type=smp

Which Firms Dominate the Antiparasitic Drugs Market by Market Share and Revenue in 2025?
Major companies operating in the antiparasitic drugs market are Pfizer Inc., Johnson & Johnson, Cadila Pharmaceuticals, Merck & Co.Inc., Bayer AG, Novartis AG, Sanofi S.A., GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim group, Zoetis Inc., Eisai Co. Ltd., Covetrus Inc., IDEXX Laboratories Inc., Dr. Reddy's Laboratories, Intas Pharmaceuticals Ltd., Alkem Laboratories Ltd., Ceva Sante Animale S.A., Elanco Animal Health Incorporated, Phibro Animal Health Corporation, Norbrook Laboratories Ltd., Mankind Pharma, Neogen Corporation, Bimeda Inc., Indoco Remedies Ltd., ECO Animal Health, Lincoln Pharmaceuticals Ltd., Laboratorios Calier.

Which Regions Offer the Highest Growth Potential in the Antiparasitic Drugs Market?
North America was the largest region in the antiparasitic drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in antiparasitic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12927

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.